12:00 AM
May 06, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Sigma-Tau sales and marketing update

Sigma-Tau launched Cystaran cysteamine ophthalmic solution in the U.S. to treat corneal cystine crystal accumulation in patients with...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >